There’s Something in the Air: Particulate Matter Pollution and Cardiovascular Disease | Cardiology Grand Rounds (RECORDING)

Thursday, October 17, 2024, 12:00 AM - Saturday, October 16, 2027, 11:59 PM, On Demand

In this recorded Cardiology Grand Rounds presentation, Dr. Brian Kim discusses particulate matter (PM) air pollution and its impact on cardiovascular health. Dr. Kim provides a comprehensive overview of PM, its history, sources, and global burden. He presents the epidemiological evidence linking PM exposure to increased cardiovascular morbidity and mortality, even at low levels. The presentation covers potential mechanisms by which PM affects cardiovascular risk factors and atherosclerosis progression. In addition, Dr. Kim emphasizes the importance of recognizing susceptible and vulnerable populations, and outlines strategies for intervention and mitigation, including patient education, air monitoring, and targeted interventions like air filtration. He also highlights emerging sources of PM exposure, such as wildfires and vaping. Overall, the presentation underscores the significant global burden of PM air pollution and the need for concerted efforts to reduce exposure and mitigate its adverse cardiovascular effects.

  Release Date: October 17th, 2024
  Expiration Date: October 16th, 2027
  Estimated Time to Complete: 0.75 hours
  Registration Fee: FREE
 *Originally recorded 02/22/2024

AMA PRA Category 1 Credits™ (0.75 hours), Non-Physician Participation Credit (0.75 hours)

1. Recognize the limitations of randomized controlled trials (RCTs), such as high costs, narrow inclusion criteria, protocol-driven care, addressing only one question, and potential obsolescence due to rapidly changing technologies or practices.
2. Raise awareness among healthcare professionals about the significant global burden of PM air pollution and the need for concerted efforts to reduce exposure and mitigate its adverse cardiovascular effects.
3. Advocate for urban infrastructure improvements, clean energy initiatives, emission trading policies, and other societal measures to reduce PM air pollution levels.
4. Incorporate PM exposure as a modifiable risk factor in cardiovascular risk assessment and management strategies.
5. Support and participate in ongoing clinical trials investigating the efficacy of air filtration interventions for mitigating the cardiovascular effects of PM exposure.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For References/Bibliography, click here.

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

 

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

 

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity. 

Faculty Member Information	Role in activity	Name of commercial interest/Nature of relationship
David Joel Maron, MD	Course Director	Membership on Advisory Committees or Review Panels, Board Membership, etc.-Abiomed, Inc.|Consulting Fee-Scilex (Relationship has ended)
Yaanik Desai, MD	Planner	Consulting Fee-Sandbox AQ (Relationship has ended)
Sneha S. Jain, MD, MBA	Planner and Reviewer	Nothing to Disclose
Brian Kim, MD, MPH	Faculty	Nothing to Disclose